Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat® inhaler versus MDI
To access this article, please choose from the options below
PII: S0954-6111(10)00044-2
doi:10.1016/j.rmed.2010.01.017
© 2010 Elsevier Ltd. All rights reserved.
